Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells
- PMID: 8643097
Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells
Abstract
The short (D2S) and long (D2L) isoforms of dopamine D2 receptors were stably expressed in Chinese hamster ovary cells, and dopamine-induced sequestration was examined by measuring the loss of binding of the hydrophilic ligand [3H]sulpiride from the cell surface. Dopamine treatment of Chinese hamster ovary cells expressing D2S for 30 min at 37 degrees caused a 43.8 +/- 3.4% decrease in [3H]sulpiride binding activity measured by incubation of the treated cells with [3H]sulpiride at 4 degrees for 4 hr after the dopamine was washed out. The half-life of the decrease in binding was estimated to be 18.7 +/- 1.6 min, and the concentration of dopamine giving a half-maximal effect (EC50) was estimated to be 180 +/- 90 nM. The decrease was reversible, and the binding activity was recovered by washing out the dopamine and incubating the cells at 37 degrees for 30 min but was not reversible when the cells were incubated at 4 degrees. The binding activity of [3H]spiperone, a hydrophobic ligand, was not affected by the dopamine treatment under the same experimental conditions. These results indicate that approximately one half of the D2S receptors undergo agonist-induced sequestration, probably endocytosis, in a reversible and temperature-dependent manner. Sequestration of D2L receptors was not as apparent as that of D2S receptors; the decrease in [3H]sulpiride binding activity was 21.6 +/- 0.9% and the rate of the decrease was delayed, with a half-life of 33.2 +/- 7.8 min, although effective concentrations of dopamine were similar, with EC50 = 170 +/- 50 nM. A D2S receptor variant containing a missense mutation changing Ser311 in the third intracellular loop to cysteine was found to be sequestered to a significantly lesser extent than with wild-type D2S receptors. This finding was discussed with respect to the report that this variant gene is found more frequently in schizophrenic patients than in control subjects.
Similar articles
-
The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells.Mol Pharmacol. 1994 May;45(5):878-89. Mol Pharmacol. 1994. PMID: 7910658
-
Paradoxical regulation of dopamine receptors in transfected 293 cells.Mol Pharmacol. 1993 Aug;44(2):371-9. Mol Pharmacol. 1993. PMID: 8102783
-
[35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.J Pharmacol Exp Ther. 1997 Jul;282(1):181-91. J Pharmacol Exp Ther. 1997. PMID: 9223553
-
Biological research on schizophrenia.Psychiatry Clin Neurosci. 1998 Dec;52 Suppl:S170-2. doi: 10.1111/j.1440-1819.1998.tb03213.x. Psychiatry Clin Neurosci. 1998. PMID: 9895138 Review.
-
Critical Impact of Different Conserved Endoplasmic Retention Motifs and Dopamine Receptor Interacting Proteins (DRIPs) on Intracellular Localization and Trafficking of the D2 Dopamine Receptor (D2-R) Isoforms.Biomolecules. 2020 Sep 23;10(10):1355. doi: 10.3390/biom10101355. Biomolecules. 2020. PMID: 32977535 Free PMC article. Review.
Cited by
-
Bidirectional Regulation of Hippocampal Synaptic Plasticity and Modulation of Cumulative Spatial Memory by Dopamine D2-Like Receptors.Front Behav Neurosci. 2022 Jan 12;15:803574. doi: 10.3389/fnbeh.2021.803574. eCollection 2021. Front Behav Neurosci. 2022. PMID: 35095441 Free PMC article.
-
Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.Pharmacol Ther. 2020 Sep;213:107583. doi: 10.1016/j.pharmthera.2020.107583. Epub 2020 May 27. Pharmacol Ther. 2020. PMID: 32473160 Free PMC article. Review.
-
Differential protein expression of DARPP-32 versus Calcineurin in the prefrontal cortex and nucleus accumbens in schizophrenia and bipolar disorder.Sci Rep. 2019 Oct 16;9(1):14877. doi: 10.1038/s41598-019-51456-7. Sci Rep. 2019. PMID: 31619735 Free PMC article.
-
Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment.Nat Commun. 2018 Jun 11;9(1):2265. doi: 10.1038/s41467-018-04711-w. Nat Commun. 2018. PMID: 29891954 Free PMC article.
-
Nigrostriatal and Mesolimbic D2/3 Receptor Expression in Parkinson's Disease Patients with Compulsive Reward-Driven Behaviors.J Neurosci. 2018 Mar 28;38(13):3230-3239. doi: 10.1523/JNEUROSCI.3082-17.2018. Epub 2018 Feb 26. J Neurosci. 2018. PMID: 29483278 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources